Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC LYG-409 | 3053857-55-6 | 98.1% | 515.44 | 25 MG
Supplier: Medchemexpress LLC 25MGHY170952
LYG-409 is an orally active degrader of GSPT1. It demonstrates excellent anti-acute myeloid leukemia and prostate cancer activity in vivo, with TGI of 94.34% and 104.49%, respectively. It inhibits KG-1 cells mediated by the degradation of GSPT1 with an IC50 of 9.50 nM, and a DC50 of 7.87 nM in vitro.
- Orally active degrader of GSPT1.
- Shows excellent anti-acute myeloid leukemia and prostate cancer activity in vivo.
- Inhibits KG-1 cells mediated by GSPT1 degradation.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?